Synagenix

At Synagenix, we are at the forefront of biotechnological innovation, dedicated to conquering neurodegenerative diseases through cutting-edge gene editing technology to provide neural rejuvenation. Our mission is to revolutionize the treatment of conditions like Alzheimer's, Parkinson's, and ALS. We envision a future where neurodegenerative diseases are no longer life sentences. Our research focuses on utilizing a novel gene-editing platform to improve the utilization of stem cell transplants, in order to develop precise, effective treatments that can halt or reverse the progression of neural disease. Our approach allows us to engineer stem cell therapies with unprecedented accuracy, offering hope for neural treatments that are both highly effective and minimally invasive.